Tags: Heart Disease | CardioMEMSHF | heart | device | fda

Remote Monitoring Device for Heart Patients

Wednesday, 04 Jun 2014 05:26 PM

 

An implanted wireless device that measures key vital signs in people with heart failure has been approved by the U.S. Food and Drug Administration.

The CardioMEMSHF system measures pulmonary artery pressure and heart rates and sends this information remotely to the patient's doctors, the FDA said in a news release.

The device is intended for people with New York Heart Association Class III heart failure, the FDA said. Some 5.8 million people in the United States have heart failure, in which the heart can't pump enough blood. People with NYHA Class III heart failure have difficulty performing everyday tasks such as walking short distances.

The device was evaluated in a clinical study involving 550 people. All devices implanted were still working after six months, the FDA said.

The agency said it is requiring a post-approval study to gather information about the device's long-term performance.

The system is manufactured by CardioMEMS Inc., based in Atlanta.

© HealthDay

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

New Psoriasis Drug

Wednesday, 21 Jan 2015 16:08 PM

A new drug to treat adults with moderate-to-severe plaque psoriasis was approved Wednesday by the U.S.Food and Drug Admi . . .

Device Fights Obesity

Wednesday, 14 Jan 2015 12:47 PM

The U.S. Food and Drug Administration said on Wednesday it has approved a new device to treat obesity, the first since 2 . . .

Long-Lasting Parkinson's Drug

Monday, 12 Jan 2015 13:11 PM

The U.S. Food and Drug Administration approved AbbVie Inc's treatment for Parkinson's disease. The treatment, Duopa - a. . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved